|
|||||
|
|
Cardiovascular and mortality risk in elderly Medicare beneficiaries treated with olmesartan versus other angiotensin receptor blockers |
|
| Authors: | David J Graham Esther H Zhou Stephen McKean Mark Levenson Katlyn Calia Kate Gelperin Xiao Ding Thomas E MaCurdy Chris Worrall Jeffrey A Kelman |
| Institution: | 1. Center for Drug Evaluation and Research, Food and Drug Administration, , Silver Spring, MD, USA;2. Acumen, LLC, , Burlingame, CA, USA;3. Stanford University, , Palo Alto, CA, USA;4. Centers for Medicare & Medicaid Services, , Washington, DC, USA |
| Abstract: | |
| Keywords: | olmesartan angiotensin receptor blockers (ARBs) cardiovascular mortality pharmacoepidemiology |